Breaks Categories: Stock Spotlights

ThursdayOct 05, 2023 12:30 pm

NetworkNewsBreaks – Electronic Servitor Publication Network Inc.’s (XESP) Digital Engagement Engine(TM) Creating Digital Experiences That Drive Growth

Electronic Servitor Publication Network (OTC: XESP) is a digital engagement company offering a Managed Service that provides unique digital activation and engagement solutions to businesses that seek to optimize growth. The company is making a difference in the global customer engagement solutions market. “The company’s Managed Service is powered by a proven, proprietary technology – the Digital Engagement Engine(TM) – which provides intelligent interaction management, dynamic content provisioning, and a logic-driven workflow, which creates digital experiences that accelerate an audience from awareness to action and drive growth. Electronic Servitor Publication Network’s Digital Engagement Engine(TM) was designed to drive growth for…

Continue Reading

MondayOct 02, 2023 3:15 pm

NetworkNewsBreaks – RJD Green Inc.’s (RJDG) Silex Holdings Seeking to Fill Niche in Growing Home Improvement Market

RJD Green’s (OTC: RJDG) subsidiary Silex Holdings Inc., a Tulsa, Oklahoma-based wholesaler and distributor of kitchen building products, has been a beneficiary of the ongoing home renovation boom. The company’s order backlog had grown to over $2,400,000 as of May 31, 2023. “A recent research report by Statista forecast that home improvement sales within the United States were expected to grow to over $620 billion by 2025, rising from a value of $538 billion in 2021. Seeking to fill an underpenetrated market niche between Home Depot and local contractor companies, Silex has sought to capitalize on the industry’s growth through…

Continue Reading

MondayOct 02, 2023 2:51 pm

NetworkNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM)-Nicotine Pouch Demonstrates Advantages over Competition

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently reported results from its human oral nicotine study NIC-H22-1, comparing Lexaria’s DehydraTECH(TM)-nicotine tobacco-free pouch to world-leading brands ZYN(R) and on! “Using measurements to determine the median time required to reach comparable nicotine concentrations within the bloodstream (‘Tmax’), Lexaria exhibited higher levels of certain pleasurable effects over the competition. DehydraTECH also provided the lowest frequency of unwanted negative effects, including moderate to severe nausea, demonstrating benefits from Lexaria’s formulation,” a recent article reads. “We’ve always had an overwhelming determination and fierce conviction that we can make the world…

Continue Reading

WednesdaySep 27, 2023 2:33 pm

NetworkNewsBreaks – Eloro Resources Ltd. (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) Poised to Help Bridge Widening Gap in Global Tin Supply Chain

Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mining company focused on developing its potential world-class Iska Iska silver-tin polymetallic property located in southern Bolivia, recently released updated assay results derived from its ongoing reconnaissance drilling. “Recent drilling work across 16 holes, spread across Eloro’s Mina Casiterita Property, Santa Barbara deposit and Porco-Mine 1 area, uncovered an array of well-mineralized intersections. Moreover and with tin mineralization at Casiterita revealed in deposits up to 2km southwest of the Santa Barbara deposit, findings suggest that Iska Iska’s cumulative mineral deposits may be far more extensive than previously anticipated,” a…

Continue Reading

WednesdaySep 27, 2023 1:50 pm

NetworkNewsBreaks – First Tellurium Corp. (CSE: FTEL) (OTC: FSTTF) Leveraging Bold New Approach to Mineral Exploration

First Tellurium (CSE: FTEL) (OTC: FSTTF), a company committed to exploring and providing critical metals, is strengthening its position in the tellurium space as a report by the U.S. Geological Survey calls tellurium “the bright future of solar energy.” “First Tellurium is exploring and developing tellurium projects in British Columbia and Colorado, confident that as the world focuses on developing green technologies, the demand for tellurium will only increase,” a recent article reads. “‘We’ve built a bold new approach to mineral exploration,’ the company states. ‘Our model is to generate revenue and investor value through mineral discovery, project development and…

Continue Reading

TuesdaySep 26, 2023 12:53 pm

NetworkNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Selected to Support California’s Criminal Justice System

SuperCom Ltd. (NASDAQ: SPCB), a leading global provider of traditional and digital identity security solutions offering advanced safety, identification, and security products and solutions to governments, recently closed a multimillion-dollar contract in California. “The contract, secured through SuperCom’s fully owned subsidiary, Leaders in Community Alternatives (‘LCA’), will see the company provide alcohol monitoring technologies and services in the state and will run until 2026, including an initial 3-year period with the potential for future extensions… The contract marks another substantial achievement for SuperCom, building on a track record of securing numerous electronic monitoring (‘EM’) contracts in the U.S. and Europe.…

Continue Reading

FridaySep 22, 2023 2:45 pm

NetworkNewsBreaks – Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) Aspiring to Change the Face of the Oil and Gas Industry

Prospera (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B), a public oil and gas exploration, exploitation and development company focused on Western Canada, appears poised for record growth. This builds on “the success from 2022, when the company realized a net income of $3.1 million and experienced rapid growth when its revenue grew by a staggering 860% in Q2 2022. Prospera Energy expects significant reductions in production costs through 2024 and sizable increases in daily production. The company is currently exploring strategic acquisition targets to diversify Prospera heavy/light/gas product mix and path to 5,000 BPD over the next 24 months while expanding…

Continue Reading

FridaySep 22, 2023 2:30 pm

NetworkNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Making Significant Strides to Advance Cellular Therapy Programs

Longeveron (NASDAQ: LGVN) is a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-related Frailty. “The company is guided by the mission to advance cell-based product candidates into pivotal phase 3 trials, with the goal of attaining regulatory approvals and subsequently commercializing the product. Longeveron has so far made significant strides in line with this mission,” reads a recent article that discussed attendance by the company’s CEO Wa’el Hashad and EVP and CFO Lisa Locklear at the recent 25th Annual H.C. Wainwright Global Investment Conference. At the…

Continue Reading

FridaySep 22, 2023 2:00 pm

NetworkNewsBreaks – RVL Pharmaceuticals plc (NASDAQ: RVLP) Anticipating Growing Demand for UPNEEQ(R)

RVL Pharmaceuticals (NASDAQ: RVLP) is a a specialty pharmaceutical company whose near-term focus is to continue the rollout of UPNEEQ(R) into the medical aesthetics market through its dedicated sales force. “UPNEEQ(R) is the first non-surgical treatment option approved by the U.S. Food and Drug Administration (‘FDA’) for acquired blepharoptosis… UPNEEQ(R), the first and only FDA-approved eye drop for low-lying eyelids, fits into the non-invasive medical aesthetics category. With a single drop per day, clinical trials showed an average of one-millimeter lift to the upper eyelid, improving appearance and the superior visual field in patients with a functional deficit. Testing also…

Continue Reading

FridaySep 22, 2023 1:47 pm

NetworkNewsBreaks – Why PaxMedica Inc. (NASDAQ: PXMD) Is ‘One to Watch’

PaxMedica (NASDAQ: PXMD) is a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic therapies (“APTs”) for the treatment of autism spectrum disorder (“ASD”) and other serious conditions with intractable neurologic symptoms. “The company’s lead programs are focused on ASD, for which there are currently no approved pharmacologic treatments that target its cause and symptoms. Currently used treatments only address the symptoms of the condition, rather than targeting the pathophysiology itself. PaxMedica is on a promising path to address these unmet medical needs, bringing hope to millions,” a recent article reads. “PaxMedica’s lead programs, PAX-101 and PAX-102, utilize…

Continue Reading